Evidence map›Paper›PMID 33403430›Full record

ArticleActa neurochirurgica2021

Utility of intraoperative ultrasonography for resection of pituitary adenomas: a comparative retrospective study.

Mohammed Alshareef, Stephen Lowe, Yeonhee Park, Bruce Frankel

Abstract readComparative Study
PubMed Publisher
In one paragraph

Article in Acta neurochirurgica, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Automatic rigid image Fusion of preoperative MR and intraoperative US acquired after craniotomy.Cancer imaging : the official publication of the International Cancer Imaging Society · 2023
    Article
  10. Article
  11. Review
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Mohammed AlshareefDepartment of Neurosurgery, Medical University of South Carolina, 301 CSB, Charleston, SC, USA. alsharee@musc.edu.ORCID http://orcid.org/0000-0001-6259-7648
Stephen LoweDepartment of NeuroOncology, Moffitt Cancer Center, Tampa, FL, USA.
Yeonhee ParkDepartment of Biostatistics and Medical Informatics, University of Wisconsi, Madison, WI, USA.
Bruce FrankelDepartment of Neurosurgery, Medical University of South Carolina, 301 CSB, Charleston, SC, USA. frankel@musc.edu.
Medical University of South Carolina · USMoffitt Cancer Center · USUniversity of Wisconsin–Madison · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe evolution of pituitary surgery has made it a safe and effective form of treatment; however, risks of inadequate tumor resection, cerebrospinal fluid (CSF) leak, pituitary dysfunction, and vascular injury still exist. The use of intraoperative ultrasonography (IOUS) in pituitary surgery has been well described. Recent advancements in ultrasound technology have allowed for expanded utility as described here.

methodsA retrospective review was performed between January 2016 and December 2019. One hundred thirty-eight patients (mean age 53.7 years, 47% females) were identified undergoing transsphenoidal surgery for pituitary tumors. Thirty-four patients had IOUS performed using a side-firing ultrasound probe, while 104 did not. Data was analyzed for preoperative (demographics, clinical, and radiographic features), perioperative (blood loss, operative time), and postoperative (complications, length of stay, hormone remission, and extent of resection) outcomes.

resultsThere were no significant differences in patient age, gender, tumor volume, Knosp grade, and hormone-secreting status between the two groups. Patients treated using IOUS had significantly higher rates of gross total resection (79% vs. 44%, p = 0.0008), shorter operative times (74 vs. 146 min, p < 0.0001), lower blood loss (119 vs. 284 cc, p < 0.0001), and hospital stays (2.9 vs. 4.2 days, p = 0.001). Overall complication rates were lower in the IOUS group compared to standard pituitary surgery but did not reach significance.

conclusionsRecent improvements in ultrasound technology have allowed for miniaturization of probes capable of delivering high-resolution images. The use of IOUS in transsphenoidal pituitary surgery may significantly increase rates of gross total resection, while decreasing blood loss, hospital LOS, and operative time.

Indexed as

Intraoperative CareUltrasonographyAdenomaFemaleHumansLength of StayMaleMiddle AgedMultivariate AnalysisOperative TimePituitary NeoplasmsPostoperative ComplicationsRetrospective StudiesIntraoperative ultrasoundNeoplasmPituitaryTranssphenoidal

Identifiers

PMID33403430
OpenAlexW3119964695

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.